Evidence map›Paper›PMID 39008798›Full record

ArticleBiochemistry2024

Roza Kalabekova, Caitlin M Quinn, Kumar Tekwani Movellan, Angela M Gronenborn, Mikael Akke, Tatyana Polenova

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biochemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Pushing Sensitivity and Specificity Limits in Native Structural Biology:Journal of the American Chemical Society · 2025
    Article
  2. Article
  3. Article
  4. IntegratingJournal of the American Chemical Society · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Roza KalabekovaDepartment of Chemistry and Biochemistry, University of Delaware, Newark, Delaware 19716, United States.ORCID 0009-0005-3985-4710
Caitlin M QuinnDepartment of Chemistry and Biochemistry, University of Delaware, Newark, Delaware 19716, United States.ORCID 0000-0001-6172-7324
Kumar Tekwani MovellanDepartment of Chemistry and Biochemistry, University of Delaware, Newark, Delaware 19716, United States.
Angela M GronenbornDepartment of Chemistry and Biochemistry, University of Delaware, Newark, Delaware 19716, United States.ORCID 0000-0001-9072-3525
Mikael AkkeDivision of Biophysical Chemistry, Center for Molecular Protein Science, Department of Chemistry, Lund University, P.O. Box 124, Lund SE-22100, Sweden.ORCID 0000-0002-2395-825X
Tatyana PolenovaDepartment of Chemistry and Biochemistry, University of Delaware, Newark, Delaware 19716, United States.ORCID 0000-0002-0346-1131

Funding

Project 3. IntegrationU54AI170791 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Peter Cherepanov · 2022 to 2026
$30.6M
NIAID NIH HHS U54 AI170791
6 · The paper itself

Abstract

Structural characterization of protein-ligand binding interfaces at atomic resolution is essential for improving the design of specific and potent inhibitors. Herein, we explored fast

Indexed as

FluorineGalectin 3GalectinsBlood ProteinsCarbohydratesHumansLigandsModels, MolecularNuclear Magnetic Resonance, BiomolecularProtein BindingProtein DomainsBlood ProteinsCarbohydratesFluorineGalectin 3GalectinsLGALS3 protein, humanLigands

Identifiers

PMID39008798
PMCPMC11702217

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.